Clinical Trials · NCT06951854
Phase II Clinical Trial to Evaluate the Efficacy and Safety of NV01-A02 in Children With Autism Spectrum Disorder
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Neuroventi Inc.
- Enrollment
- 105
- Start date
- Apr 2025
- Locations
- 1 site, South Korea
- Primary endpoint
- Change from baseline in the composite scores of the major domains of the Korean Vineland Adaptive Behavior Scales-II (K-Vineland-II) at Week 8 after administration.